Last updated: December 13, 2023
Sponsor: University Ghent
Overall Status: Active - Recruiting
Phase
N/A
Condition
Autism Spectrum Disorder (Asd)
Treatment
Assessment
Clinical Study ID
NCT06183411
ONZ-2023-0329
Ages 6-12 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age of child: from six to 12 years old
- Confirmed diagnosis of DCD by a multidisciplinary team (including a physician)
- Child lives in Flanders or the Netherlands
- Child has Dutch as the mother tongue
Exclusion
Exclusion Criteria:
- Diagnosis of autism spectrum disorder (ASD)
- Blood related siblings of the child
- Parent/legal guardian does not have an adequate level of Dutch
- (IQ lower than 70) OR (no IQ information and child attends special education type 1 (mild intellectual disability) or type 2 (moderate to severe mental disability))
Study Design
Total Participants: 90
Treatment Group(s): 1
Primary Treatment: Assessment
Phase:
Study Start date:
November 17, 2023
Estimated Completion Date:
October 30, 2024
Connect with a study center
Universiteit Gent - Vakgroep revalidatiewetenschappen
Ghent,
BelgiumActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.